Synthesize Bio
Phase 1/2AI-powered gene expression models predict human tissue responses to drugs. De-risk clinical trials, optimize patient selection, and accelerate drug development.
Founded
2021
Focus
AI / Machine Learning
About
AI-powered gene expression models predict human tissue responses to drugs. De-risk clinical trials, optimize patient selection, and accelerate drug development.
Company Info
TypePrivate
Founded2021
LocationSan Francisco, United States
StagePhase 1/2
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile